馃嚝馃嚪 Cellectis
ALCLS.PAFundamentals
Gross Margin
72.5%
Op. Margin
-55.3%
Net Margin
-92.7%
ROIC
-48.0%
Rev Growth
82.9%
Valuation
Price
2.95 EUR
Day
+5.36%
52-Week Range
2.03 - 4.84
Market Cap
297M EUR
Fwd P/E
-
EV/EBITDA
-
Div Yield
-
Annual income statement #
Cellectis annual revenue, operating income and net income in EUR, 2016 to 2025. Revenue was 75.9m in 2025.
| Year | Revenue (EUR) | Operating income | Net income | Net margin |
|---|---|---|---|---|
| 2025 | 75.9m | -42.0m | -70.3m | -92.7% |
| 2024 | 41.5m | -59.6m | -36.8m | -88.6% |
| 2023 | 755,000 | -97.3m | -101.1m | |
| 2022 | 19.2m | -89.7m | -98.7m | |
| 2021 | 73.9m | -85.4m | -86.3m | |
| 2020 | 73.9m | -85.4m | -72.6m | -98.1% |
| 2019 | 15.2m | -123.6m | -90.7m | |
| 2018 | 12.7m | -105.1m | -78.7m | |
| 2017 | 25.2m | -92.7m | -99.4m | |
| 2016 | 42.6m | -64.0m | -63.9m |
Financial Data #
Segment Breakdown #
Peers #
VICO.ST EGTX.ST ALVIO.PA TNG.PA ORY.MC HNSA.ST IPH.PA ATRY.MC ONWD.BR VLA.PA 路
Compare in Screener
Dividends
Bubble
Short Interest #
Current: 1.00% 路
30d ago: 1.30% 路
All-time high: 2.17% (2016-02-26)
Events #
| Date | Type | Details | Price | Amount |
|---|